The FDA has expanded the approval of Odactra to include treatment of house dust mite-induced allergic rhinitis in pediatric patients aged 5 to 11 years.
iX Biopharma is transforming approved drugs such as ketamine into novel therapies using its wafer-based sublingual technology, to develop therapies for pain, depression and more. Since its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback